s6y

3 Deciphera Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities

Filed
Period
Accession number
0000899243-18-013542

Documents

  1. FORM 3 SUBMISSION 3
  2. EX-24 DOCUMENT EX-24

On sec.gov